Search research articles
Contact Us
Filters
Showing results (181-190 of 228) with videos related to
Page
of 23
Sort By:
Gastroenterology
|
June 13, 2012
Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1
Nuria Martínez-López, Juan L García-Rodríguez, Marta Varela-Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
Xinhua Song, Xianqiong Liu, Haichuan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Antonio Cigliano, Isabella Gigante, Marina Serra, et al.
Gut
|
September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer
Steffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Genes, Chromosomes & Cancer
|
April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays
Martina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2023
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Gastroenterology
|
February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma
Darjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Cancer Research
|
September 12, 2025
Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
Guofei Cui, Yi Zhou, Weiting Liao, et al.
Genes, Chromosomes & Cancer
|
October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 228) with videos related to
Sort By:
Page
of 23
Gastroenterology
|
June 13, 2012
Hepatoma cells from mice deficient in glycine N-methyltransferase have increased RAS signaling and activation of liver kinase B1
Nuria Martínez-López, Juan L García-Rodríguez, Marta Varela-Rey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 8, 2018
Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma
Xinhua Song, Xianqiong Liu, Haichuan Wang, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
September 6, 2024
HSF1 is a prognostic determinant and therapeutic target in intrahepatic cholangiocarcinoma
Antonio Cigliano, Isabella Gigante, Marina Serra, et al.
Gut
|
September 12, 2021
Histone H3K27 demethylase KDM6A is an epigenetic gatekeeper of mTORC1 signalling in cancer
Steffie Revia, Agnieszka Seretny, Lena Wendler, et al.
Genes, Chromosomes & Cancer
|
April 23, 2020
NTRK testing: First results of the QuiP-EQA scheme and a comprehensive map of NTRK fusion variants and their diagnostic coverage by targeted RNA-based NGS assays
Martina Kirchner, Julia Glade, Ulrich Lehmann, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 2, 2022
The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 16, 2023
Correction: The Hippo pathway efector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease
Antonio Cigliano, Shanshan Zhang, Silvia Ribback, et al.
Gastroenterology
|
February 20, 2013
Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma
Darjus Felix Tschaharganeh, Xin Chen, Philipp Latzko, et al.
Cancer Research
|
September 12, 2025
Inhibition of GSK3 and TSC2 Mediates the Oncogenic Activity of AKT in Hepatocellular Carcinoma
Guofei Cui, Yi Zhou, Weiting Liao, et al.
Genes, Chromosomes & Cancer
|
October 26, 2019
Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays
Nicole Pfarr, Martina Kirchner, Ulrich Lehmann, et al.
Page
of 23